Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Miranda

Showing results (171-180 of 175) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 175 results.
Emerging Infectious Diseases|January 26, 2022
High-Dose Convalescent Plasma for Treatment of Severe COVID-19Gil C De Santis, Luciana Correa Oliveira, Pedro M M Garibaldi, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|March 14, 2023
Colchicine reduces the activation of NLRP3 inflammasome in COVID-19 patientsN B Amaral, T S Rodrigues, M C Giannini, et al.
RMD Open|February 5, 2021
Beneficial effects of colchicine for moderate to severe COVID-19: a randomised, double-blinded, placebo-controlled clinical trialMaria Isabel Lopes, Leticia P Bonjorno, Marcela C Giannini, et al.
Antiviral Research|July 11, 2020
Sofosbuvir shows a protective effect against vertical transmission of Zika virus and the associated congenital syndrome in rhesus monkeysNoemi R Gardinali, Renato S Marchevsky, Jaqueline M Oliveira, et al.
Arquivos Brasileiros De Cardiologia|September 14, 2013
[First guidelines of the Brazilian Society of Cardiology on Cardiopulmonary Resuscitation and Cardiovascular Emergency Care]M M Gonzalez, S Timerman, R Gianotto-Oliveira, et al.
Pageof 18

Showing results (171-180 of 175) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 175 results.
Emerging Infectious Diseases|January 26, 2022
High-Dose Convalescent Plasma for Treatment of Severe COVID-19Gil C De Santis, Luciana Correa Oliveira, Pedro M M Garibaldi, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|March 14, 2023
Colchicine reduces the activation of NLRP3 inflammasome in COVID-19 patientsN B Amaral, T S Rodrigues, M C Giannini, et al.
RMD Open|February 5, 2021
Beneficial effects of colchicine for moderate to severe COVID-19: a randomised, double-blinded, placebo-controlled clinical trialMaria Isabel Lopes, Leticia P Bonjorno, Marcela C Giannini, et al.
Antiviral Research|July 11, 2020
Sofosbuvir shows a protective effect against vertical transmission of Zika virus and the associated congenital syndrome in rhesus monkeysNoemi R Gardinali, Renato S Marchevsky, Jaqueline M Oliveira, et al.
Arquivos Brasileiros De Cardiologia|September 14, 2013
[First guidelines of the Brazilian Society of Cardiology on Cardiopulmonary Resuscitation and Cardiovascular Emergency Care]M M Gonzalez, S Timerman, R Gianotto-Oliveira, et al.
Pageof 18